Tessera Therapeutics at ASH 2026
Dec 12–15, 2026 New Orleans, LA ~30k attendees Website
Tessera Therapeutics brings 3 presentations to ASH 2026 in New Orleans. Its research centres on editing genes inside the body to treat blood disease. It covers correcting sickle cell disease in stem cells and making CAR-T cells in vivo using lipid nanoparticles.
| Organization | ASH 2026 Attendance |
|---|---|
Tessera Therapeutics Somerville, MA | |
Biotechnology company developing genetic medicines using gene writing. | Poster Sat Dec 12 5:30pm–7:30pm Oral Mon Dec 14 10:30am–12:00pm |
Find decision makers at Tessera Therapeutics
Tell us what you sell and we’ll find the people at Tessera Therapeutics most likely to buy it.
- Who to contact
- Their contact info
- What to say
- Free, no sign-up
Not affiliated with or endorsed by the American Society of Hematology (ASH). Submit a correction